EN DE
STOCK COMPARISON

Lantheus Holdings vs Jiangsu Hengrui Medicine Co: Fair Value & Quality

Both stocks run through our valuation models. Here is how Lantheus Holdings (LNTH) and Jiangsu Hengrui Medicine Co (600276) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Lantheus Holdings as the less overvalued of the two: Lantheus Holdings trades at $101 versus a fair value of $78.92 (-22%), while Jiangsu Hengrui Medicine Co trades at ¥54.62 versus ¥25.94 (-53%).
Lantheus Holdings
LNTH · USD · Health Care
-22%
upside to fair value
overvalued
Price$101
Fair Value$78.92
Quality65/100
Jiangsu Hengrui Medicine Co
600276.SHG · CNY · Health Care
-53%
upside to fair value
overvalued
Price¥54.62
Fair Value¥25.94
Quality66/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Lantheus HoldingsJiangsu Hengrui Medicine Co
Valuation
25.1×P/E (TTM)43.6×
4.43×P/S (TTM)10.84×
6.28×P/B5.76×
19.3×EV/EBITDA33.0×
0.61×PEG0.93×
—Dividend yield0.4%
—Dividend per share¥0.20
Profitability
18%Net margin25%
22%Operating margin32%
23%Return on equity15%
8%Return on assets9%
Growth
1%Revenue growth (YoY)13%
18.1%Avg. growth/yr (3Y)13.9%
35.3%Avg. growth/yr (5Y)2.5%
Balance & size
0.52×Debt / equity—
$7BMarket cap$52B
healthyGrowth qualityhealthy

Lantheus Holdings leads: 7 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Lantheus Holdingsof which business quality 66 · market factors 77 Jiangsu Hengrui Medicine Coof which business quality 68 · market factors 46
ProfitabilityMargins and returns on capital today
66
63
Quality GrowthAre margins and returns improving?
9
41
CashflowEarnings quality: real cash, not paper profit
88
82
Fin. StrengthBalance sheet, leverage, solvency risk
80
100
InvestmentDisciplined investing over empire-building
34
27
Low VolatilityCalm price path (market factor)
61
78
MomentumPrice trend over the last 3–12 months (market factor)
85
35
52W MomentumDistance to the 52-week high (market factor)
81
29
Net IssuanceBuybacks instead of dilution
97
64

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Lantheus Holdings

DCF Models$110
Earnings-Based$56.39
Dividend Discount$0.52
Multiples$69.47
Asset-Based$11.21
Growth DCF$112
Economic Profit$42.24
Growth Earnings$85.48

18 of 26 models see the stock below the current price.

Jiangsu Hengrui Medicine Co

DCF Models¥37.78
Earnings-Based¥21.29
Dividend Discount¥3.82
Multiples¥23.65
Asset-Based¥6.44
Growth DCF¥39.88
Economic Profit¥18.21
Growth Earnings¥30.99

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Lantheus Holdings
Bear $59.19Fair Value $78.92Bull $111
$101 = current price (white tick)
Jiangsu Hengrui Medicine Co
Bear ¥19.95Fair Value ¥25.94Bull ¥40.28
¥54.62 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Lantheus Holdings · Health Care

Quality score65 · Top 25%
Fair value upside-22% · above median

Jiangsu Hengrui Medicine Co · Health Care

Quality score66 · Top 25%
Fair value upside-53% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Lantheus Holdings as the less overvalued of the two: Lantheus Holdings trades at $101 versus a fair value of $78.92 (-22%), while Jiangsu Hengrui Medicine Co trades at ¥54.62 versus ¥25.94 (-53%).

Jiangsu Hengrui Medicine Co has the higher quality score (66/100).

See the full analysis →
Lantheus Holdings · Jiangsu Hengrui Medicine Co

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Lantheus Holdings

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Jiangsu Hengrui Medicine Co

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.